ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL - ALTA SRL - Italy 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:600-700
Total Number of Projects:67
Total Project Funding:700-800
Networking Rank (Reputation):700-800
Networking Rank (Reputation):700-800
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:900-1000
Total Number of Projects:> 1000
Total Project Funding:400-500
Networking Rank (Reputation):900-1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Total Project Funding:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 22
As coordinator: 0
As participant: 22
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 1.000.615 0 1
2018 0 7.437.128 190.000 1
2017 0 13.594.515 465.383 2
2016 0 11.365.807 180.000 3
2015 0 9.404.500 200.000 2
2014 0 5.982.400 150.000 1
2013 0 14.741.378 440.000 3
2012 0 17.897.850 1.089.539 4
2011 0 35.293.677 354.601 3
2010 0 16.360.905 525.200 2

Networking:

Partners:

Institution:Projects [No]:
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD8
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
CONSIGLIO NAZIONALE DELLE RICERCHE5
INSTITUT PASTEUR4
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
KING'S COLLEGE LONDON3
UNIVERSITA DEGLI STUDI DI GENOVA3
UNIVERSITAETSKLINIKUM FREIBURG3
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
CELLOGIC2
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
FONDAZIONE HUMANITAS PER LA RICERCA2
FONDAZIONE PER L'ISTITUTO DI RICERC A IN BIOMEDICINA2
FUNDACAO OSWALDO CRUZ2
FUNDACIO INSTITUT CATALA DE NANOCIENCIA I NANOTECNOLOGIA2
GENOME IDENTIFICATION DIAGNOSTICS2
GLAXOSMITHKLINE VACCINES2
HOOKIPA BIOTECH2
HOSPICES CANTONAUX CHUV2
ICON CLINICAL RESEARCH LIMITED2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
ISTITUTO SUPERIORE DI SANITA2
KAROLINSKA INSTITUTE2
KLINIKUM DER UNIVERSITAET REGENSBURG2
LUNDS UNIVERSITET2
MILTENYI BIOTEC2
PLURISTEM2
SANTARIS PHARMA2
THE UNIVERSITY OF MANCHESTER2
UNIVERSITAET INNSBRUCK2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITE DE GENEVE2
UNIVERSITY COLLEGE LONDON2
UNIVERSITY OF ABERDEEN2
UNIVERSITY OF BIRMINGHAM2
ABERA BIOSCIENCE AB1
ABS INTERNATIONAL1
ACADEMISCH ZIEKENHUIS LEIDEN1
ALERGENETICA SL1
ALFA WASSERMANN1
ALFASIGMA1
AMBIOTIS SAS1
ANAXOMICS BIOTECH S L1
APOINTECH SL1
APPLIED NANOPARTICLES SL1
ARENAVAX1
ASKLEPIOS KLINIKEN HAMBURG1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTELLAS PHARMA EUROPE B V1
ATLAS BIOLABS1
AVANTICELL SCIENCE1
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO1
BE THE PARTNER1
BE THE PARTNER INC1
BERING LIMITED1
BIOMEDCODE HELLAS1
BIOMEDICAL RESEARCH FOUNDATION ACADEMY OF ATHENS1
BIONEEDLE TECHNOLOGIES GROUP BV1
BLUSENSE DIAGNOSTICS APS1
BRISTOL MYERS SQUIBB INTERNATIONAL CORPORATION1
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST1
CARDIFF UNIVERSITY1
CENIX BIOSCIENCE1
CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH CO1
CLINIT1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSORZIO ITALBIOTEC1
CROSSBETA BIOSCIENCES BV1
DEBIOPHARM1
DEPARTMENT OF HEALTH1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
DIAGNOSTICUM GYARTO ES FORGALMAZO ZARTKORUEN MUKODO RESZVENYTARSASAG1
DOMPE FARMACEUTICI1
DOMPE PHA R MA1
DUOTOL AB1
DYNETIX1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECOAST1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
ELECTRO SCIENTIFIC INDUSTRIES EUROPE1
EMORY UNIVERSITY NON PROFIT CORP1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE1
EUROPEAN LIVER PATIENTS ASSOCIATION1
FONDAZIONE POLIAMBULANZA1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA1
GENOWAY1
GLAXOSMITHKLINE BIOLOGICALS1
GLYCOUNIVERSE GMBH & CO KOMMANDITGESELLSCHAFT AUF AKTIEN1
GOETEBORGS UNIVERSITET1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
GSK VACCINES INSTITUTE FOR GLOBAL HEALTH1
HACETTEPE UNIVERSITESI1

Constancy:

Total number of partners: 268
Partner loyalty:
Frequent Partner: (> 2 projects): 40
Rare Partner: 228
Frequent / Rare Partner Ratio: 0.18

Project overview:

Start dateProjectacronymrolefundingpartners
2019-01-01Quantitative detection of bacterial endotoxin by novel nanotechnological approaches ENDONANOparticipant1.000.6159
2018-01-01Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial HIPGENparticipant7.437.12812
2017-01-01A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies PACEparticipant7.595.7158
2017-01-01SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS LIVERHOPEparticipant5.998.80018
2016-11-01Improving the flow in the pipeline of the next generation of marine biodiscovery scientists MarPipeparticipant2.853.00514
2016-01-01Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. HEP-CARparticipant5.698.31010
2016-01-01Probing safety of nano-objects by defining immune responses of environmental organisms PANDORAparticipant2.814.49112
2015-11-01A training network for the rational design of the next generation of well-defined glycoconjugate vaccines GLYCOVAXparticipant3.554.50012
2015-05-01An integrated approach to dissect determinants, risk factors and pathways of ageing of the immune system. ImmunoAgeingparticipant5.850.0004
2014-02-01Biomarker Development for Postoperative Cognitive Impairment in the Elderly BIOCOGparticipant5.982.40012
2013-10-01Human cystic Echinococcosis ReseArch in CentraL and Eastern Societies HERACLESparticipant2.861.50010
2013-09-01Targeting and exploiting B cell functions for treatment in cardiovascular disease ATHERO-B-CELLparticipant5.892.17811
2013-09-01Targeting novel lipid pathways for treatment of cardiovascular disease ATHERO-FLUXparticipant5.987.70011
2012-11-01Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation BIO-DRIMparticipant5.989.00017
2012-11-01"Pathogen COinfection: HIV, Tuberculosis, Malaria and Hepatitis C virus" PATHCOparticipant5.909.69011
2012-01-01Targeting Src-family tyrosine kinases in chronic autoimmune and inflammatory diseases TARKINAIDparticipant2.999.86011
2012-01-01TargetIng novel MEchanisms of Resolution in inflammation TIMERparticipant2.999.30013
2011-10-01Advanced Immunization Technologies ADITECparticipant29.980.67052
2011-10-01Enable the powder metallurgy process to expand to new markets with more reliable parts and lower manufacturing costs through the inspection of green parts DIRA-GREENparticipant2.347.80014
2011-03-01Integrating chemical approaches to treat pancreatic cancer: making new leads for a cure Panacreasparticipant2.965.20712
2010-12-01"Fungi in the setting of inflammation, allergy and autoimmune diseases:Translating basic science into clinical practices" ALLFUNparticipant5.524.70414
2010-11-01A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation THE ONE STUDYparticipant10.836.20116

Alias institution names:

  • ALTA LAB
  • ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA
  • ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU